New York MDRU
New York, 10010, United States
NCT Number: NCT00015275
The purpose of this study is to define pathophysiological subtypes of abnormalities in subjects with cocaine dependence.
Looking for future studies?
Notify MeMale
Interventional
Phase 4
New York, 10010, United States
The objective of this study is to define subgroups of patients with differential treatment outcome on the basis of differential baseline electrophysiological clusters.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Cocaine dependence. Seeking residential treatment.
National Institute on Drug Abuse (NIDA)
Nih
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00232336
Behavior, Behavior, Addictive
Tacoma, Washington, United States
View Trial DetailsNCT00000216
Chemically-Induced Disorders, Cocaine-Related Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT00000311
Chemically-Induced Disorders, Cocaine-Related Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT00000271
Behavior, Behavioral Symptoms
New York, United States
View Trial Details